Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ZS
|
Remo Canessa
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,212 Reduced 1.46% |
$641,340
$199.67 p/Share
|
Dec 18
2024 |
|
EVER
|
David Brainard
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 21,079 Reduced 15.35% |
$380,054
$18.03 p/Share
|
Dec 18
2024 |
|
DSGN
|
Deepa Prasad |
SELL
Open market or private sale
|
Direct | 3,806 Reduced 15.99% |
$23,863
$6.27 p/Share
|
Dec 18
2024 |
|
ZS
|
Robert Schlossman
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 3,035 Reduced 2.67% |
$583,509
$192.26 p/Share
|
Dec 18
2024 |
|
GH
|
Musa Tariq
Director |
SELL
Open market or private sale
|
Direct | 116 Reduced 3.96% |
$4,042
$34.85 p/Share
|
Dec 18
2024 |
|
RNA
|
Teresa Mc Carthy
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 11,151 Reduced 11.86% |
$364,191
$32.66 p/Share
|
Dec 18
2024 |
|
RNA
|
Sarah Boyce
President and CEO |
SELL
Open market or private sale
|
Direct | 31,855 Reduced 10.72% |
$1,040,384
$32.66 p/Share
|
Dec 18
2024 |
|
RNA
|
Michael F Mac Lean
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 11,151 Reduced 11.85% |
$364,191
$32.66 p/Share
|
Dec 18
2024 |
|
RNA
|
W. Michael Flanagan
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 12,742 Reduced 14.92% |
$416,153
$32.66 p/Share
|
Dec 18
2024 |
|
CLXT
|
Gerhard Prante
Director |
SELL
Open market or private sale
|
Direct | 1,150 Reduced 2.14% |
$4,312
$3.75 p/Share
|
Dec 18
2024 |
|
PHR
|
David Linetsky
SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect | 24 Reduced 0.0% |
$609
$25.38 p/Share
|
Dec 18
2024 |
|
PHR
|
Allison C Hoffman
General Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 3,495 Reduced 2.92% |
$86,955
$24.88 p/Share
|
Dec 18
2024 |
|
COCO
|
Martin F Roper
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 8,984 Reduced 0.0% |
$319,650
$35.58 p/Share
|
Dec 18
2024 |
|
COCO
|
Martin F Roper
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 4,394 Reduced 1.3% |
$156,558
$35.63 p/Share
|
Dec 18
2024 |
|
ESRT
|
Thomas P. Durels
EVP, Real Estate |
SELL
Open market or private sale
|
Direct | 3,193 Reduced 3.19% |
$34,803
$10.9 p/Share
|
Dec 18
2024 |
|
ADGI
|
Terrance Mcguire |
SELL
Open market or private sale
|
Indirect | 74,764 Reduced 0.0% |
$35,139
$0.47 p/Share
|
Dec 18
2024 |
|
SEMR
|
Dmitry Melnikov
Director |
SELL
Open market or private sale
|
Indirect | 44,592 Reduced 0.0% |
$568,993
$12.76 p/Share
|
Dec 18
2024 |
|
KBDC
|
Susan C Schnabel
Director |
BUY
Open market or private purchase
|
Direct | 2,500 Added 23.61% |
$41,350
$16.54 p/Share
|
Dec 18
2024 |
|
MRAM
|
David Schrenk
VP SALES & BUS. DEVELOPMENT |
SELL
Open market or private sale
|
Direct | 2,381 Reduced 2.53% |
$14,833
$6.23 p/Share
|
Dec 18
2024 |
|
CNC
|
Thomas Greco
Director |
BUY
Open market or private purchase
|
Direct | 17,000 Added 46.82% |
$1,015,750
$59.75 p/Share
|
Dec 18
2024 |
|
PINS
|
Gokul Rajaram
Director |
SELL
Open market or private sale
|
Direct | 1,150 Reduced 3.53% |
$35,627
$30.98 p/Share
|
Dec 18
2024 |
|
DY
|
Jennifer M Fritzsche |
SELL
Open market or private sale
|
Direct | 430 Reduced 4.62% |
$74,437
$173.11 p/Share
|
Dec 18
2024 |
|
NET
|
Thomas J Seifert
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 5.6% |
$1,700,700
$113.38 p/Share
|
Dec 18
2024 |
|
VRNT
|
Grant A Highlander
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 12,880 Reduced 9.91% |
$376,740
$29.25 p/Share
|
Dec 18
2024 |
|
DFH
|
Patrick O. Zalupski
President and CEO |
SELL
Open market or private sale
|
Direct | 18,439 Reduced 0.94% |
$487,342
$26.43 p/Share
|
Dec 18
2024 |
|
ESTC
|
Ashutosh Kulkarni
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 7,017 Reduced 1.74% |
$758,678
$108.12 p/Share
|
Dec 18
2024 |
|
SNA
|
Aldo John Pagliari
Sr VP - Finance & CFO |
SELL
Open market or private sale
|
Direct | 6,909 Reduced 6.42% |
$2,395,350
$346.7 p/Share
|
Dec 18
2024 |
|
RMAX
|
Adam K Peterson
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 29,455 Added 0.91% |
$318,703
$10.82 p/Share
|
Dec 18
2024 |
|
NRDS
|
Samuel Yount
Chief Business Officer |
SELL
Open market or private sale
|
Indirect | 154,465 Reduced 0.0% |
$2,029,670
$13.14 p/Share
|
Dec 18
2024 |
|
COUR
|
Andrew Y. Ng |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 0.34% |
$218,750
$8.75 p/Share
|
Dec 18
2024 |
|
ATUS
|
Next Alt S.A.R.L. |
SELL
Open market or private sale
|
Direct | 805,230 Reduced 8.16% |
$19,728,135
$24.5 p/Share
|
Dec 18
2024 |
|
DV
|
Nicola T Allais
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,071 Reduced 2.35% |
$42,476
$20.51 p/Share
|
Dec 18
2024 |
|
DSAC
|
Gerald Yao
CSO and Director |
SELL
Open market or private sale
|
Indirect | 2,750 Reduced 0.0% |
$4,125
$1.5 p/Share
|
Dec 18
2024 |
|
LMFA
|
Ryan H Duran
Vice President of Operations |
SELL
Open market or private sale
|
Direct | 500 Reduced 3.75% |
$1,290
$2.58 p/Share
|
Dec 18
2024 |
|
SNX
|
Marshall Witt
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,510 Reduced 3.03% |
$182,906
$121.13 p/Share
|
Dec 18
2024 |
|
TXO
|
Keith A Hutton
Director |
BUY
Open market or private purchase
|
Direct | 60,000 Added 1.44% |
$962,400
$16.04 p/Share
|
Dec 18
2024 |
|
CRCT
|
Len Blackwell
Director |
SELL
Open market or private sale
|
Indirect | 48,040 Reduced 0.0% |
$307,936
$6.41 p/Share
|
Dec 18
2024 |
|
FTNT
|
Ken Xie
PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct | 22,928 Reduced 0.05% |
$2,200,170
$95.96 p/Share
|
Dec 18
2024 |
|
UTHR
|
Louis W Sullivan |
SELL
Open market or private sale
|
Direct | 26,209 Reduced 83.84% |
$9,812,125
$374.38 p/Share
|
Dec 18
2024 |
|
ALK
|
Joseph A Sprague |
SELL
Open market or private sale
|
Direct | 2,325 Reduced 10.73% |
$149,683
$64.38 p/Share
|
Dec 18
2024 |
|
AIP
|
Saiyed Atiq Raza |
SELL
Open market or private sale
|
Indirect | 12,166 Reduced 0.0% |
$122,511
$10.07 p/Share
|
Dec 18
2024 |
|
ALK
|
Emily Halverson
VP Finance, Controller & Treas |
SELL
Open market or private sale
|
Direct | 1,329 Reduced 15.67% |
$85,600
$64.41 p/Share
|
Dec 18
2024 |
|
STRL
|
Dana C. O'Brien
Director |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 7.17% |
$351,780
$175.89 p/Share
|
Dec 18
2024 |
|
XLO
|
Gilead Sciences Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1,759,978 Added 16.2% |
$1,830,377
$1.04 p/Share
|
Dec 18
2024 |
|
FMBM
|
Charles C. Driest
EVP/Chief Experience Officer |
BUY
Open market or private purchase
|
Direct | 546 Added 10.06% |
$10,838
$19.85 p/Share
|
Dec 18
2024 |
|
ACR-PD
|
Eagle Point Credit Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 5,500 Reduced 0.0% |
$138,490
$25.18 p/Share
|
Dec 18
2024 |
|
ACR-PD
|
Eagle Point Credit Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,316 Reduced 0.0% |
$30,360
$23.07 p/Share
|
Dec 18
2024 |
|
WEAV
|
Alan Taylor
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 12,044 Reduced 4.02% |
$194,510
$16.15 p/Share
|
Dec 18
2024 |
|
AIP
|
K Charles Janac
President and CEO |
SELL
Open market or private sale
|
Indirect | 12,621 Reduced 0.0% |
$127,093
$10.07 p/Share
|
Dec 18
2024 |
|
SES
|
Sk Inc. |
SELL
Open market or private sale
|
Direct | 400,000 Reduced 1.24% |
$168,000
$0.42 p/Share
|
Dec 18
2024 |